NEUROSCIENCE 2027 – The 3rd Global Summit on Neuroscience, Neurology and Brain Disorders will bring researchers, clinicians, academics, technology innovators and healthcare industry leaders together in Zurich on March 29–30, 2027.
The rapidly evolving science of the human brain is entering an era defined by convergence. Neuroscience is no longer confined to laboratories and specialist clinical departments. Advances in artificial intelligence, neuroimaging, genomics, regenerative medicine, brain-computer interfaces, neurotechnology and precision medicine are increasingly reshaping how neurological and neuropsychiatric disorders are understood, diagnosed and treated.
Against this backdrop, the 3rd Global Summit on Neuroscience, Neurology and Brain Disorders — NEUROSCIENCE2027 — is set to take place on March 29–30, 2027, in Zurich, Switzerland.
Organised by Research Connects, the summit is designed as an international forum for scientific exchange, research presentation, professional networking and industry collaboration across neuroscience, neurology and brain disorders. The organisers describe the meeting as an opportunity to explore new research and business potential while connecting researchers and students with industry specialists and translating scientific work into real-world applications.
HealthViews India is proud to be associated with NEUROSCIENCE2027 as its media partner, bringing the summit and its scientific conversations to a wider healthcare, medical and health-technology audience in India and beyond.
A global meeting focused on the future of brain science
NEUROSCIENCE2027 is positioned as a multidisciplinary global summit rather than a narrowly focused neurology meeting. Its programme spans basic neuroscience, clinical neurology, neuropsychiatry, neurotechnology, artificial intelligence, brain ageing, neurodegeneration, regenerative medicine and emerging approaches to precision neurological care.
The event is expected to feature plenary and keynote lectures, invited and oral presentations, poster presentations, panel discussions, workshops, networking opportunities and an industry exhibition. The official programme currently lists two days of scientific sessions, with plenary and keynote sessions on Day 1 followed by invited, oral and scientific presentations on Day 2.
The summit’s broader objective is to create a meeting point between scientific discovery and practical implementation — bringing together those who generate knowledge, those who apply it in clinical settings and those developing technologies, products and services for the neurological healthcare ecosystem.
When and where is NEUROSCIENCE2027 being held?
Event: 3rd Global Summit on Neuroscience, Neurology and Brain Disorders
Official event name: NEUROSCIENCE2027
Dates: March 29–30, 2027
Location: Zurich, Switzerland
Organiser: Research Connects
Event website: neurology.researchconnects.org
Email: neuroscience2027@researchconnects.org
Conference Manager: Ch. Poornima
Phone / WhatsApp: +91 7674987428
Zurich provides an appropriate setting for an international meeting of this nature. The city combines strong international connectivity with a major European research and innovation ecosystem. The conference brochure highlights Zurich’s location on Lake Zurich, proximity to the Swiss Alps, efficient transportation, walkability, cultural institutions and international accessibility.
The organisers have not specified a final conference venue/address in the brochure or the main event information currently available online; attendees should therefore check the official event website for venue confirmation and updates closer to the summit.
What will NEUROSCIENCE2027 cover?
The scientific scope of the summit is extensive, reflecting the increasingly interconnected nature of brain science.
The brochure lists topics ranging from molecular and cellular neuroscience to clinical neurology, neuroengineering and neuropsychiatry.
The current online programme further expands the scientific agenda to include:
- Stroke recovery and neurovascular advances
- Neuropsychiatry and brain-behaviour disorders
- Neuroinflammation and the brain-immune axis
- Brain ageing and longevity science
- Artificial intelligence in neurology and neuroimaging
- NeuroAI and brain-inspired computing
- Brain-computer interfaces and neural interfaces
- Wearable neurotechnology and digital biomarkers
- Big data and predictive neurology
- Gene therapy and precision neurology
- Epigenetics and brain plasticity
- Stem cells and neural regeneration
- Neuromodulation and adaptive brain stimulation
- Personalised neurological medicine
- Synapse biology and glial mechanisms
- Mitochondrial dysfunction in brain disease
- Single-cell brain mapping and spatial omics
- Biomarkers and neurodiagnostics
- Neuroethics and brain-data governance
- Neurotechnology policy and regulation
- Mental-health innovation and public-health neuroscience
- Neuroentrepreneurship and industry collaboration
- Translational neuroscience
- Alzheimer’s disease, Parkinson’s disease and dementia
- Computational neuroscience and brain modelling
- Paediatric neurology and neurodevelopmental disorders
- Neuropharmacology and drug discovery
- Sleep medicine and circadian neuroscience.
This breadth is particularly relevant at a time when the boundaries between neuroscience, medicine, engineering, data science and digital health are becoming increasingly fluid.
Also Read: CardioDiabetes Synergy Symposium 3.0 – Four Seasons, One Mission
Artificial intelligence and the changing face of neuroscience
One of the notable themes running through the NEUROSCIENCE2027 programme is the growing role of artificial intelligence in brain science.
AI is represented through areas such as AI-enabled neuroimaging, NeuroAI, brain-inspired computing, predictive neurology, multimodal biomarkers and neurophysiological data analysis.
Among the speakers listed by the organisers is Prof. Andrés Quintero Zea of EIA University, Colombia, whose presentation focuses on artificial intelligence and neurophysiological data for next-generation neuroscience. Another featured speaker, Dr. NagaRaj Halemani of India’s iBrains Centre for Precision Neuropsychiatry, is scheduled to address explainable multimodal AI for precision diagnosis of mild cognitive impairment in Alzheimer’s disease.
The programme also includes AI and machine-learning expertise through Mrs. Jahnavi Kachhia, Global Product Owner – AI & ML, who is listed among the summit’s panel speakers in the conference brochure.
The inclusion of these themes reflects a broader transformation underway in neurological medicine: the movement from traditional diagnosis towards data-driven, multimodal and potentially personalised approaches to understanding brain disorders.
Alzheimer’s, Parkinson’s and neurodegenerative disease
Neurodegenerative disorders form another major component of the summit.
Alzheimer’s disease, dementia, Parkinson’s disease, neurodegenerative diseases, brain ageing and challenges in diagnosing neurodegenerative disorders are specifically included in the programme.
The current website also lists a plenary presentation by Dr. Lloyd L. Tran, Chairman and CEO of Biomed Industries, focusing on the neurogenesis hypothesis and evidence from Phase 2 clinical trials of NA-831 for Alzheimer’s disease.
This focus comes at a critical time for global healthcare systems. Population ageing is increasing the number of people living with dementia and other age-associated neurological conditions, while researchers are pursuing earlier diagnosis, biomarkers, disease-modifying therapies, regenerative approaches and personalised interventions.
The summit provides a platform for these different approaches to be discussed alongside developments in neuroscience and translational medicine.
Brain-computer interfaces, neurotechnology and the next generation of neurological care
NEUROSCIENCE2027 also looks beyond conventional clinical neuroscience.
Brain-computer interfaces, neural interfaces, wearable neurotechnology, digital biomarkers, neuroengineering, signal processing and neuromodulation feature prominently in the scientific programme.
The conference brochure similarly identifies neuroengineering and signal processing, neurophysiology, CNS injury and repair, and neurosurgery and spine among its areas of interest.
These technologies are increasingly relevant to rehabilitation, assistive technologies, neurological monitoring, diagnostics and potentially new therapeutic strategies. Bringing engineers, neuroscientists, clinicians and industry stakeholders into the same forum can help accelerate conversations around how emerging technologies move from research environments towards real-world healthcare applications.
Also Read: Artificial Organs and Implants: A New Era in Organ Transplants
Regenerative medicine, stem cells and precision neurology
The summit’s agenda also extends into regenerative medicine and advanced therapeutic approaches.
Topics include stem cells and neural regeneration, gene therapy, precision neurology, molecular genetics, neurobiology, neuroplasticity and drug development.
India’s presence is also visible among the listed speakers. Dr. Pradeep Mahajan of StemRx Bioscience Solutions is included in the speaker roster, while Dr. NagaRaj Halemani represents India’s growing intersection of neuroscience, precision medicine and artificial intelligence.
The participation of researchers and professionals working across different therapeutic and technological areas underlines the summit’s translational focus — connecting laboratory discoveries with potential clinical and commercial applications.
NEUROSCIENCE 2027 – Speaker and Organising Committee
NEUROSCIENCE2027 brings together speakers and organising committee members from multiple countries and institutions.
The organising committee includes:
- Dr. Chris Stout — University of Illinois, USA
- Prof. Luiz Moutinho — University of Suffolk, UK
- Dr. Lloyd L. Tran — Biomed Industries, USA
- Mrs. Jahnavi Kachhia — Global Product Owner, AI & ML, USA
- Ify Nwiwu — University of Sunderland in London, UK
- Prof. Marco Carotenuto — University of Campania, Italy
- Dr. Bernd Blobel — University of Regensburg, Germany
- Prof. Michel Lagarde — University of Lyon, France
- Dr. Frederick Wittke — Arthama GmbH, Switzerland
- Dr. Horng-Dar Wang — National Tsing Hua University, Taiwan
- Dr. Mohita Shrivastava — Cognitome LLC, Dubai
- Dr. Mohammad Kamil — Lotus Holistic Institute, UAE
- Prof. Andrés Quintero Zea — EIA University, Colombia
- Prof. Meera Vaswani — WHO Drug Dependence Centre, India.
The summit’s local chair is Dr. Frederick Wittke, Co-Founder of Arthama GmbH, Switzerland, while Prof. Codrina Ancuta of Grigore T. Popa University of Medicine and Pharmacy of Iasi, Romania, is listed as Co-Chair.
The speaker roster includes experts from the United States, United Kingdom, Switzerland, Italy, Turkey, India, Colombia, Canada, Brazil, Morocco, Egypt, Denmark, Pakistan and other countries, demonstrating the international character of the meeting.
Who should attend NEUROSCIENCE2027?
According to the organisers, the summit is intended for a broad professional and academic audience.
Potential participants include:
- Professors
- Associate professors
- Assistant professors
- PhD scholars
- Graduates and postgraduate students
- Researchers
- Clinicians and healthcare professionals
- Directors and CEOs of organisations
- Heads of departments
- Professional and scientific associations
- Research institutes and their members
- Training institutes
- Industry representatives and business delegates
- Product manufacturers and technology companies.
For researchers and faculty members, participation can include oral presentations, poster displays, symposium hosting and workshop organisation.
Universities, associations and professional societies can participate through academic partnerships, collaboration proposals, group participation and association partnering.
Students and research scholars can take part through poster presentations, the Young Researcher Forum, student attendance and group registrations. Business delegates can participate through presentations, symposium hosting, networking and audience engagement.
Opportunities for researchers to present their work
For researchers, one of the principal attractions of NEUROSCIENCE2027 is the opportunity to present current research to an international audience.
Participation options include:
Oral presentations: Researchers and faculty can present their work through scientific oral sessions.
Poster presentations: A platform for researchers and students to showcase findings and interact with other participants.
Symposium hosting: Researchers can organise a four- to five-member symposium team.
Workshops: Participants can propose and organise workshops around relevant areas of expertise.
Young Researcher Forum: Students and early-career researchers have an opportunity to participate in a dedicated platform.
Academic collaboration: Universities, associations and research organisations can explore institutional partnerships and collaborative opportunities.
The official abstract submission portal is available through the event website. Submit an Abstract for NEUROSCIENCE2027
Conference programme: What can attendees expect?
The current online programme is structured over two conference days.
Day 1 — March 29, 2027
8:00–9:00 — Registration
9:00–9:15 — Introduction and Opening Words
9:15–11:00 — Plenary Sessions
11:00–11:20 — Refreshments / Coffee Break
11:20–13:00 — Plenary Sessions
13:00–14:00 — Lunch with Table Discussions
14:00–15:40 — Keynote Presentations
15:40–16:00 — Refreshments / Coffee Break
16:00–17:30 — Keynote Presentations
Day 2 — March 30, 2027
9:00–9:30 — Registration
9:30–11:00 — Invited / Oral Presentations
11:00–11:20 — Refreshments / Coffee Break
11:20–13:00 — Invited / Oral Presentations
13:00–14:00 — Lunch with Table Discussions
14:00–15:40 — Invited / Oral Presentations
15:40–16:00 — Refreshments / Coffee Break
16:00–17:30 — Oral Presentations.
The schedule gives the summit a strong scientific orientation while leaving room for informal discussion and networking through coffee breaks and table discussions.
Registration fees for NEUROSCIENCE2027
The official registration page currently lists three registration stages – Early bird registration, mid-term registration and final registration for students, speakers, delegates and exhibitors.
Registration includes access to conference sessions, opportunities for eligible participants to give keynote/plenary, poster or workshop presentations, an organising-committee certificate, and tea/coffee, snacks and lunch during the conference.
The brochure additionally lists discounts for group participation: 10% for groups of five, 15% for groups of 10 and 25% for groups of 20. It also mentions a 25% discount for participants attending from local universities and organisations.
View the official NEUROSCIENCE2027 registration page.
Why the NEUROSCIENCE 2027 Summit matters for the Global Neurological Community
The importance of a multidisciplinary neuroscience meeting lies in the opportunity to connect scientific disciplines that are often separated by institutional and professional boundaries.
Neurological disorders can involve genetics, inflammation, metabolism, vascular biology, immune mechanisms, ageing, behaviour, cognition and environmental influences. At the same time, emerging technologies such as AI, advanced imaging, wearable sensors, neuroprosthetics and brain-computer interfaces are changing the tools available to researchers and clinicians.
NEUROSCIENCE2027’s programme reflects this convergence.
Its themes move from cell and molecular biology to AI; from neurogenomics to neuroengineering; from Alzheimer’s and Parkinson’s disease to brain-computer interfaces; and from regenerative medicine to neuroethics and technology regulation.
This makes the summit relevant not only to traditional neuroscience and neurology researchers but also to professionals working in digital health, biotechnology, medical devices, artificial intelligence, rehabilitation, pharmaceuticals, diagnostics and healthcare innovation.
A platform for global collaboration
The organisers place particular emphasis on networking and collaboration.
The conference brochure identifies three major objectives: global networking, discovering the latest research and encouraging industry collaboration. The stated aim is to connect scientists, researchers, clinicians and industry professionals while creating opportunities to translate research into practical applications.
For younger researchers and students, such international meetings can also provide opportunities to engage with established researchers, explore research collaborations and gain exposure to scientific work beyond their immediate institutions.
The summit specifically encourages students, PhD scholars, graduates and postgraduate participants to take part.
NEUROSCIENCE 2027 Important Dates: What Prospective Participants Should Know
There is an important point for prospective attendees and researchers: the dates published on the brochure and the live event website have been updated at different times and do not fully match.
The brochure lists:
- Abstract submission deadline: August 25, 2026
- Early-bird registration: August 14, 2026
- Standard registration deadline: September 25, 2026.
However, the current official website displays different deadlines. Its abstract-submission page currently lists October 10, 2026 as the abstract deadline, September 12, 2026 for early-bird registration, October 15, 2026 for standard registration and March 29, 2027 for on-the-spot registration.
The registration page likewise presents registration stages with dates of August 29, 2026, August 31, 2026, and March 29, 2027.
Because these dates have changed across the event’s published materials, researchers and delegates should verify the applicable deadline directly on the official website before submitting an abstract or making payment.
HealthViews India: Bringing the conversation to a wider healthcare audience
As the media partner for NEUROSCIENCE2027, HealthViews Online / HealthViews India will help amplify the scientific and healthcare conversations emerging from the summit for readers across India and the wider healthcare ecosystem.
For India’s rapidly expanding neuroscience, neurology, medical technology and healthcare innovation communities, international platforms such as NEUROSCIENCE2027 can provide valuable opportunities to engage with global research, explore collaborations and understand emerging directions in brain health.
The participation of Indian professionals in the summit — including researchers and experts working in regenerative medicine, precision neuropsychiatry and public-health-related fields — also highlights the increasingly international role of Indian healthcare and scientific communities.
The road to Zurich
With its combination of neuroscience, clinical neurology, neurotechnology, artificial intelligence, regenerative medicine, neurodegenerative disease research and industry collaboration, NEUROSCIENCE2027 aims to create a broad international forum for the future of brain science.
The event will bring together established researchers and emerging scientists, clinicians and academics, technology innovators and industry representatives, with opportunities to present research, discuss emerging discoveries, develop collaborations and explore potential applications.
For researchers looking to present their work, students seeking international exposure, clinicians following developments in neurological medicine, technology companies working in neurotechnology and organisations seeking scientific partnerships, the summit offers several routes for participation.
The organisers’ central message is straightforward: the future of neuroscience will depend on collaboration across disciplines and borders.
And in March 2027, that conversation will move to Zurich.
NEUROSCIENCE2027 — At a Glance
| Event Detail | Information |
|---|---|
| Event | 3rd Global Summit on Neuroscience, Neurology and Brain Disorders |
| Short Name | NEUROSCIENCE2027 |
| Dates | March 29–30, 2027 |
| Location | Zurich, Switzerland |
| Organiser | Research Connects |
| Format | Plenary, keynote, invited, oral and poster presentations, networking and exhibition |
| Major Themes | Neuroscience, neurology, brain disorders, AI, neurotechnology, neurodegeneration, regenerative medicine, precision neurology and more |
| Audience | Researchers, clinicians, professors, students, PhD scholars, healthcare professionals, industry, associations and technology companies |
| Speaker Registration | From US$749 |
| Delegate Registration | From US$899 |
| Poster Registration | From US$449 |
| Student Registration | From US$299 |
| Sponsorship | Platinum US$5,000; Gold US$4,000; Silver US$3,000; Exhibitor US$2,000 |
| Abstract Submission | Through the official NEUROSCIENCE2027 website |
| Official Website | neurology.researchconnects.org |
| Contact | neuroscience2027@researchconnects.org |
| Conference Manager | Ch. Poornima |
| Phone / WhatsApp | +91 7674987428 |
| Media Partner | HealthViews India |
Note: Registration fees and deadlines are subject to change. The live Research Connects website should be treated as the latest source for registration, abstract submission and programme updates.
